by Wendy Diller
Nearly three years ago, the FDA approved Genentech Inc. 's breast cancer drug, trastuzumab (Herceptin). It was a milestone for diagnostic companies. For the first time, the FDA required...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?